A detailed history of Verity & Verity, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Verity & Verity, LLC holds 2,790 shares of NVO stock, worth $243,762. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,790
Previous 3,990 30.08%
Holding current value
$243,762
Previous $569,000 41.65%
% of portfolio
0.03%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.07 - $145.42 $142,884 - $174,503
-1,200 Reduced 30.08%
2,790 $332,000
Q2 2024

Nov 07, 2024

BUY
$122.71 - $146.91 $85,897 - $102,837
700 Added 25.09%
3,490 $498,000
Q2 2024

Sep 16, 2024

BUY
$122.71 - $146.91 $61,355 - $73,455
500 Added 14.33%
3,990 $569,000
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $428,257 - $512,715
3,490 New
3,490 $498,000
Q1 2024

Nov 07, 2024

BUY
$102.11 - $135.92 $71,477 - $95,143
700 Added 25.09%
3,490 $448,000
Q1 2024

Sep 16, 2024

BUY
$102.11 - $135.92 $51,055 - $67,960
500 Added 14.33%
3,990 $512,000
Q3 2023

Nov 07, 2024

BUY
$90.94 - $199.54 $45,470 - $99,770
500 Added 17.92%
3,290 $299,000
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $123,405 - $270,775
1,357 Added 70.2%
3,290 $299,000
Q2 2023

Nov 07, 2024

SELL
$155.98 - $172.65 $133,674 - $147,961
-857 Reduced 30.72%
1,933 $312,000
Q2 2023

Jul 10, 2023

SELL
$155.98 - $172.65 $48,665 - $53,866
-312 Reduced 13.9%
1,933 $312,000
Q1 2023

Nov 07, 2024

SELL
$132.34 - $159.14 $72,125 - $86,731
-545 Reduced 19.53%
2,245 $357,000
Q1 2023

May 02, 2024

BUY
$132.34 - $159.14 $297,103 - $357,269
2,245 New
2,245 $357,000
Q4 2022

Jan 11, 2023

SELL
$102.55 - $135.33 $107,677 - $142,096
-1,050 Reduced 31.87%
2,245 $0
Q1 2022

May 03, 2022

BUY
$93.1 - $112.54 $120,564 - $145,739
1,295 Added 64.75%
3,295 $366,000
Q3 2021

Nov 04, 2021

BUY
$84.42 - $106.62 $168,840 - $213,240
2,000 New
2,000 $231,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Verity & Verity, LLC Portfolio

Follow Verity & Verity, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.